Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Baric

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Plos One|December 8, 2022
Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical centerHeather B Root, Matt Gilleskie, Chih-Huan Lu, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected MiceAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Research Square|November 14, 2023
Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirusMark Heise, Jacob Dillard, Sharon Taft-Benz, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Human Coronavirus HKU1 Neutralizing Monoclonal Antibodies Target Diverse Epitopes Within and Around the TMPRSS2 Receptor Binding SiteLingshu Wang, Jeswin Joseph, Sheena Vasquez, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Phylogeny-driven design of broadly protective sarbecovirus receptor-binding domain nanoparticle vaccinesAmin Addetia, Alexandra Schäfer, Kaitlin Sprouse, et al.
Biorxiv : the Preprint Server for Biology|August 15, 2020
<i>De novo</i> design of ACE2 protein decoys to neutralize SARS-CoV-2Thomas W Linsky, Renan Vergara, Nuria Codina, et al.
Iscience|February 3, 2025
MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodiesOlubukola M Abiona, Nianshuang Wang, Sarah R Leist, et al.
Nature Communications|November 30, 2023
Engineered immunogens to elicit antibodies against conserved coronavirus epitopesA Brenda Kapingidza, Daniel J Marston, Caitlin Harris, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus EpitopesBrenda Kapingidza, Daniel J Marston, Caitlin Harris, et al.
The New England Journal of Medicine|September 29, 2020
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsEvan J Anderson, Nadine G Rouphael, Alicia T Widge, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Plos One|December 8, 2022
Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical centerHeather B Root, Matt Gilleskie, Chih-Huan Lu, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected MiceAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Research Square|November 14, 2023
Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirusMark Heise, Jacob Dillard, Sharon Taft-Benz, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Human Coronavirus HKU1 Neutralizing Monoclonal Antibodies Target Diverse Epitopes Within and Around the TMPRSS2 Receptor Binding SiteLingshu Wang, Jeswin Joseph, Sheena Vasquez, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Phylogeny-driven design of broadly protective sarbecovirus receptor-binding domain nanoparticle vaccinesAmin Addetia, Alexandra Schäfer, Kaitlin Sprouse, et al.
Biorxiv : the Preprint Server for Biology|August 15, 2020
<i>De novo</i> design of ACE2 protein decoys to neutralize SARS-CoV-2Thomas W Linsky, Renan Vergara, Nuria Codina, et al.
Iscience|February 3, 2025
MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodiesOlubukola M Abiona, Nianshuang Wang, Sarah R Leist, et al.
Nature Communications|November 30, 2023
Engineered immunogens to elicit antibodies against conserved coronavirus epitopesA Brenda Kapingidza, Daniel J Marston, Caitlin Harris, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus EpitopesBrenda Kapingidza, Daniel J Marston, Caitlin Harris, et al.
The New England Journal of Medicine|September 29, 2020
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsEvan J Anderson, Nadine G Rouphael, Alicia T Widge, et al.
Pageof 8